LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
Hormone and Metabolic Modulators S5
Acetyl Tetrapeptide-3 supports follicles and how hair appears with consistent use
Aldea R, Weller RO, Wilcock DM, Carare RO, Richardson G
Generation of human vascularized brain organoids
Here are the top root causes we look for, summarized into four main categories: Physical obstructions Physical obstructions can impair outflow through the intestines